Cargando…
Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
We conducted a cohort study to assess vaccine effectiveness (VE) of coronavirus disease 2019 vaccine combinations on severe acute respiratory syndrome coronavirus 2 critical infection and death among elderly population in Korea. From January to August 2022, VE against death for 4 doses mRNA recipien...
Autores principales: | Park, Seon Kyeong, Choe, Young June, Jang, Eun Jung, Kim, Ryu Kyung, Lee, Sang-Won, Kwon, Geun-Yong, Shin, Jeeyeon, Choi, Sang-Yoon, Jeong, Mi Jin, Park, Young-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186072/ https://www.ncbi.nlm.nih.gov/pubmed/37191847 http://dx.doi.org/10.3346/jkms.2023.38.e143 |
Ejemplares similares
-
Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents
por: Kim, Yoo-Yeon, et al.
Publicado: (2022) -
Effectiveness of A Fourth Dose of COVID-19 mRNA Vaccine in the Elderly Population During the Omicron BA.2 and BA.5 Circulation: A Nationwide Cohort Study in Korea (K-COVE)
por: Park, Seon Kyeong, et al.
Publicado: (2023) -
Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
por: Kim, Ryu Kyung, et al.
Publicado: (2023) -
Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
por: Jang, Eun Jung, et al.
Publicado: (2022) -
Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022
por: Lim, Do Sang, et al.
Publicado: (2022)